BRIEF-Vaxart Completes Enrollment In Phase 1 Trial For Its Norovirus Oral Pill Vaccine Candidate

Reuters
Yesterday
BRIEF-Vaxart Completes Enrollment In Phase 1 Trial For Its Norovirus Oral Pill Vaccine Candidate

April 30 (Reuters) - Vaxart Inc VXRT.O:

  • VAXART COMPLETES ENROLLMENT IN PHASE 1 TRIAL FOR ITS NOROVIRUS ORAL PILL VACCINE CANDIDATE

  • VAXART INC - TOPLINE DATA FROM PHASE 1 TRIAL EXPECTED MID-2025

  • VAXART INC - PLANS PHASE 2 STUDY FOR NOROVIRUS VACCINE IN SECOND HALF 2025

  • VAXART INC - PHASE 3 TRIAL FOR NOROVIRUS VACCINE COULD BEGIN IN 2026

Source text: ID:nGNXfVBrR

Further company coverage: VXRT.O

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10